ClinicalTrials.gg
Active, not recruitingNCT07886814TEP-CATUpdated Oct 23, 2026

Urinary Catheterization Versus No Catheterization in Laparoscopic Total Extraperitoneal Inguinal Hernia Repair

An interventional study of Routine Urinary Catheterization and No Routine Urinary Catheterization in Inguinal Hernias, sponsored by Ugur Duman. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Ugur Duman · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2026, registered Oct 2026).
Updated Oct 23, 2026Eligibility revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled clinical trial is to determine whether avoiding routine urinary catheterization reduces postoperative urinary symptoms in patients undergoing laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.

The main questions it aims to answer are:

  • Does avoiding routine urinary catheterization reduce the incidence of dysuria on postoperative day 1?
  • Does avoiding routine urinary catheterization reduce postoperative urinary or urethral pain without increasing urinary retention or other complications? Researchers will compare patients undergoing laparoscopic TEP inguinal hernia repair with routine urinary catheterization to those undergoing the same procedure without urinary catheterization.

Participants will:

  • Undergo laparoscopic TEP inguinal hernia repair with or without routine urinary catheterization according to randomized group assignment.
  • Complete postoperative assessments of urinary symptoms and complications on days 1, 10, and 30.
  • Undergo follow-up for inguinal hernia recurrence for six months after surgery.
Read the detailed description

Routine urinary catheterization is commonly performed during laparoscopic totally extraperitoneal (TEP) inguinal hernia repair to maintain bladder decompression and facilitate preperitoneal dissection. However, catheter placement may cause postoperative urinary discomfort and urethral irritation. The clinical necessity of routine catheterization during TEP repair remains uncertain.

This prospective, single-center, randomized controlled trial was designed to evaluate the effects of routine urinary catheterization on postoperative urinary symptoms and surgical safety.

All procedures were performed under general anesthesia by a single surgeon with 24 years of surgical experience. A standardized laparoscopic TEP technique was used in both groups. The preperitoneal working space was established using balloon dissection, followed by identification and dissection of the hernia sac and exposure of the myopectineal orifice. A polypropylene mesh was placed to cover the myopectineal orifice, with limited fixation. Hemostasis was confirmed, and no surgical drains were routinely placed.

In the catheterization group, the urinary catheter was maintained throughout the immediate postoperative period and removed before discharge, approximately 24 hours after surgery. Patients in the no-catheterization group underwent the same surgical procedure without routine urinary catheter placement.

Postoperative urinary symptoms were evaluated through patient-reported assessments and clinical follow-up. Urinary or urethral pain intensity was measured using a 0-10 visual analog scale (VAS), with higher scores indicating greater pain intensity.

The study was designed to assess whether omission of routine urinary catheterization could improve postoperative patient comfort while maintaining the safety of laparoscopic TEP inguinal hernia repair.

02

Conditions studied

  • Inguinal Hernias

Browse trials for

Keywords

  • Urinary Catheterization
  • Laparoscopic Inguinal Hernia Repair
  • Total Extraperitoneal Repair
  • Postoperative Dysuria
  • Urethral Pain
  • Randomized Controlled Trial
03

In context

Hernia, Inguinal

561 studies on the registry are indexed under Hernia, Inguinal; 76 are open to participants now.

This study's enrollment of 100 is above the median of 90 across 414 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Ugur Duman is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Clinical or radiological diagnosis of inguinal hernia.
  • Scheduled to undergo laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.

Exclusion criteria

Exclusion Criteria:

  • Scrotal inguinal hernia.
  • Prolapsed inguinal hernia.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    No Urinary Catheterization

    Participants assigned to this group underwent laparoscopic total extraperitoneal (TEP) inguinal hernia repair without routine perioperative urinary catheterization. The surgical procedure was performed under general anesthesia using a standardized technique. Postoperative urinary symptoms, urinary retention, and surgical complications were assessed during follow-up.

    Procedure: No Routine Urinary Catheterization

  • Active comparator
    Routine Urinary Catheterization

    Participants assigned to this group underwent laparoscopic totally extraperitoneal (TEP) inguinal hernia repair with routine perioperative urinary catheterization. A urinary catheter was placed during the perioperative period and removed before hospital discharge, approximately 24 hours after surgery. Postoperative urinary symptoms, urinary retention, and surgical complications were assessed during follow-up.

    Procedure: Routine Urinary Catheterization

Interventions

  • ProcedureRoutine Urinary Catheterization

    Routine perioperative urinary catheterization was performed in participants undergoing laparoscopic total extraperitoneal inguinal hernia repair. The urinary catheter was maintained during the immediate postoperative period and removed before hospital discharge, approximately 24 hours after surgery.

  • ProcedureNo Routine Urinary Catheterization

    Participants underwent laparoscopic total extraperitoneal inguinal hernia repair without routine perioperative urinary catheter placement. Postoperative urinary symptoms and urinary retention were assessed using the same follow-up schedule as the catheterization group.

06

What researchers measure

Primary outcomes

  1. Incidence of Dysuria on Postoperative Day 1

    The primary outcome was the incidence of postoperative dysuria, defined as patient-reported pain, burning, or discomfort during urination within the first 24 hours following laparoscopic total extraperitoneal inguinal hernia repair. Dysuria was assessed as a binary outcome (present or absent). The proportion of participants experiencing dysuria was compared between the urinary catheterization and no-catheterization groups.

    Time frame: Postoperative Day 1 (within 24 hours after surgery)

Secondary outcomes

  1. Incidence of Urinary or Urethral Pain on Postoperative Day 1

    The presence of urinary or urethral pain was assessed on postoperative day 1 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain was considered present when the VAS score was greater than 0. The proportion of participants reporting pain was compared between the two study groups.

    Time frame: Postoperative Day 1 (within 24 hours after surgery)

  2. Incidence of Urinary or Urethral Pain on Postoperative Day 10

    Urinary or urethral pain was assessed on postoperative day 10 using a 0-10 visual analog scale (VAS). Pain was classified as present when the VAS score was greater than 0. The incidence of pain was compared between the urinary catheterization and no-catheterization groups.

    Time frame: Postoperative Day 10

  3. Incidence of Urinary or Urethral Pain on Postoperative Day 30

    Urinary or urethral pain was assessed on postoperative day 30 using a visual analog scale (VAS) ranging from 0 to 10. Pain was defined as a VAS score greater than 0. The proportion of participants reporting pain was evaluated in each intervention group.

    Time frame: Postoperative Day 30

  4. Urinary or Urethral Pain Severity on Postoperative Day 1

    The severity of urinary or urethral pain was assessed using an 11-point visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores were compared between the urinary catheterization and no-catheterization groups.

    Time frame: Postoperative Day 1

  5. Urinary or Urethral Pain Severity on Postoperative Day 10

    Urinary or urethral pain intensity was measured using a 0-10 visual analog scale (VAS) on postoperative day 10. Higher scores indicated greater pain intensity.

    Time frame: Postoperative Day 10

  6. Urinary or Urethral Pain Severity on Postoperative Day 30

    Urinary or urethral pain intensity was evaluated on postoperative day 30 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: Postoperative Day 30

  7. Incidence of Urinary or Urethral Pain During the First 30 Postoperative Days

    The composite incidence of postoperative urinary or urethral pain was defined as the presence of pain (VAS score greater than 0) at any of the scheduled postoperative assessments on days 1, 10, or 30. Participants reporting pain at least once during the follow-up period were classified as having experienced urinary or urethral pain. The proportion of affected participants was compared between the two groups.

    Time frame: Postoperative Days 1, 10, and 30

  8. Incidence of Postoperative Urinary Retention

    Postoperative urinary retention was assessed during postoperative follow-up. The incidence of urinary retention was recorded as a binary outcome (present or absent), and the proportion of affected participants was compared between the urinary catheterization and no-catheterization groups.

    Time frame: Within 30 days after surgery

  9. Incidence of Postoperative Complications

    Postoperative complications were assessed during the first 30 days after laparoscopic TEP inguinal hernia repair. Recorded complications included urinary retention, scrotal emphysema, and scrotal ecchymosis. The proportion of participants experiencing at least one postoperative complication was compared between the intervention groups.

    Time frame: Within 30 days after surgery

  10. Incidence of Inguinal Hernia Recurrence Within Six Months

    Hernia recurrence was assessed during a six-month postoperative follow-up period. Recurrence was defined as the reappearance of an inguinal hernia following laparoscopic TEP repair, as identified through postoperative clinical evaluation. The proportion of participants experiencing recurrence was compared between the two intervention groups.

    Time frame: Up to 6 months after surgery

07

Study locations

1 site
  • Bursa Yuksek Ihtisas Training and Research Hospital
    Bursa, 16310, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available due to patient confidentiality considerations and the absence of a predefined individual participant data-sharing plan in the study protocol.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in Jun 2026, 3 months.

Of 181 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's 3 months is below that.

Counting every sponsor, half of 190 studies reached it within 17 months; a quarter within 8 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 21, 2026
StartActual
Mar 1, 2026
Primary completionActual
Jun 1, 2026
CompletionEst.
Nov 1, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility
Registered
First appeared on the registry
Oct 21, 2026
Show all 2 updates
  1. Oct 23, 2026
    Eligibility Criteria revised
    + 1 other change: description
  2. Oct 21, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07886814
Lead sponsor
Ugur Duman
Responsible party
Ugur Duman (Assistant Professor of General Surgery, Bursa Yuksek Ihtisas Training and Research Hospital) — Sponsor-investigator
First posted
Oct 21, 2026
Start date
Mar 1, 2026
Primary completion
Jun 1, 2026
Completion
Nov 1, 2026 (estimated)
Last update
Oct 23, 2026

Study contacts

Ugur Duman, MD
principal investigator · Bursa Yuksek Ihtisas Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion